Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q50884218
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010720.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q50884218
|
024
|
|
|
‡a
0000-0002-5813-332X
‡2
orcid
|
024
|
|
|
‡a
7006188042
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q50884218
|
100
|
0 |
|
‡a
Ângela Maria Moraes
‡9
ast
‡9
es
‡9
sl
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Ângela Maria Moraes
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Ângela Maria Moraes
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Advances in the Use of Supercritical Fluids for the Production of Poly
|
670
|
|
|
‡a
Author's Advances in the Use of Supercritical Fluids for the Production of Poly(α-hydroxyester) Particles Incorporating Bioactive Agents
|
670
|
|
|
‡a
Author's Analysis of process parameters on the characteristics of liposomes prepared by ethanol injection with a view to process scale-up: Effect of temperature and batch volume
|
670
|
|
|
‡a
Author's Analysis of the performance of polysaccharide membranes in aqueous media as a tool to assist wound-dressing selection
|
670
|
|
|
‡a
Author's Antibacterial and non-cytotoxic ultra-thin polyethylenimine film.
|
670
|
|
|
‡a
Author's Avaliação do potencial antioxidante de extratos ativos de plantas obtidos por extração com fluido supercrítico
|
670
|
|
|
‡a
Author's Behavior of wild-type and transfected S2 cells cultured in two different media.
|
670
|
|
|
‡a
Author's BIOMATERIALS: TYPES, APPLICATIONS, AND MARKET
|
670
|
|
|
‡a
Author's Characterization of chitosan and polycaprolactone membranes designed for wound repair application
|
670
|
|
|
‡a
Author's Characterization of coatings for open-heart surgery tubing with heparin and lipid.
|
670
|
|
|
‡a
Author's Chitosan-alginate membranes accelerate wound healing.
|
670
|
|
|
‡a
Author's Coated electrospun bioactive wound dressings: Mechanical properties and ability to control lesion microenvironment
|
670
|
|
|
‡a
Author's Combining xanthan and chitosan membranes to multipotent mesenchymal stromal cells as bioactive dressings for dermo-epidermal wounds.
|
670
|
|
|
‡a
Author's Comparative study on complexes formed by chitosan and different polyanions: Potential of chitosan-pectin biomaterials as scaffolds in tissue engineering
|
670
|
|
|
‡a
Author's Comparison of the properties of compacted and porous lamellar chitosan-xanthan membranes as dressings and scaffolds for the treatment of skin lesions
|
670
|
|
|
‡a
Author's Comparison of the properties of membranes produced with alginate and chitosan from mushroom and from shrimp.
|
670
|
|
|
‡a
Author's Composite membranes of alginate and chitosan reinforced with cotton or linen fibers incorporating epidermal growth factor.
|
670
|
|
|
‡a
Author's Control of the properties of porous chitosan-alginate membranes through the addition of different proportions of Pluronic F68.
|
670
|
|
|
‡a
Author's Culture of transgenic Drosophila melanogaster Schneider 2 cells in serum-free media based on TC100 basal medium
|
670
|
|
|
‡a
Author's Development of polysaccharide-based membranes incorporating the bioactive compound aloin
|
670
|
|
|
‡a
Author's Development of porous lamellar chitosan-alginate membranes: Effect of different surfactants on biomaterial properties
|
670
|
|
|
‡a
Author's Differentiation of dental pulp stem cells into chondrocytes upon culture on porous chitosan-xanthan scaffolds in the presence of kartogenin
|
670
|
|
|
‡a
Author's Dispersion and release of embelin from electrospun, biodegradable, polymeric membranes
|
670
|
|
|
‡a
Author's Drosophila melanogaster S2 cells for expression of heterologous genes: From gene cloning to bioprocess development
|
670
|
|
|
‡a
Author's Effects of chitosan solution concentration and incorporation of chitin and glycerol on dense chitosan membrane properties
|
670
|
|
|
‡a
Author's Effects of different sterilization methods on the morphology, mechanical properties, and cytotoxicity of chitosan membranes used as wound dressings
|
670
|
|
|
‡a
Author's Effects of Electrospun Fibrous Membranes of PolyCaprolactone and Chitosan/Poly(Ethylene Oxide) on Mouse Acute Skin Lesions
|
670
|
|
|
‡a
Author's Effects of supercritical carbon dioxide processing on the properties of chitosan–alginate membranes
|
670
|
|
|
‡a
Author's Electrospun multilayer chitosan scaffolds as potential wound dressings for skin lesions
|
670
|
|
|
‡a
Author's Encapsulamento do 5-fluorouracil em lipossomas para administração tópica
|
670
|
|
|
‡a
Author's Enhancement of cellular activity in hyperglycemic mice dermal wounds dressed with chitosan-alginate membranes
|
670
|
|
|
‡a
Author's Enhancement of Sf9 Cells and Baculovirus Production Employing Grace's Medium Supplemented with Milk Whey Ultrafiltrate.
|
670
|
|
|
‡a
Author's Evaluation of concentrated milk whey as a supplement for SF9 Spodoptera frugiperda cells in culture
|
670
|
|
|
‡a
Author's Evaluation of in vitro anti-inflammatory effects of crude ginger and rosemary extracts obtained through supercritical CO2 extraction on macrophage and tumor cell line: the influence of vehicle type
|
670
|
|
|
‡a
Author's Formation of PLA particles incorporating 17α-methyltestosterone by supercritical fluid technology
|
670
|
|
|
‡a
Author's Formulation of a protein-free medium based on IPL-41 for the sustained growth of Drosophila melanogaster S2 cells.
|
670
|
|
|
‡a
Author's Growth of recombinant Drosophila melanogaster Schneider 2 cells producing rabies virus glycoprotein in bioreactor employing serum-free medium
|
670
|
|
|
‡a
Author's Hyaluronan/chitosan nanofilms assembled layer-by-layer and their antibacterial effect: A study using Staphylococcus aureus and Pseudomonas aeruginosa.
|
670
|
|
|
‡a
Author's Improvement of the mechanical properties of chitosan-alginate wound dressings containing silver through the addition of a biocompatible silicone rubber
|
670
|
|
|
‡a
Author's INCORPORATION AND RELEASE KINETICS OF ALPHA-BISABOLOL FROM PCL AND CHITOSAN/GUAR GUM MEMBRANES
|
670
|
|
|
‡a
Author's Influence of a triazine derivative-based biocide on microbial biofilms of cutting fluids in contact with different substrates
|
670
|
|
|
‡a
Author's Influence of culture conditions on recombinant Drosophila melanogaster S2 cells producing rabies virus glycoprotein cultivated in serum-free medium
|
670
|
|
|
‡a
Author's Influence of the incorporation of the antimicrobial agent polyhexamethylene biguanide on the properties of dense and porous chitosan-alginate membranes
|
670
|
|
|
‡a
Author's Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment
|
670
|
|
|
‡a
Author's Kinetic response of a Drosophila melanogaster cell line to different medium formulations and culture conditions.
|
670
|
|
|
‡a
Author's Mechanically-enhanced polysaccharide-based scaffolds for tissue engineering of soft tissues
|
670
|
|
|
‡a
Author's Nomenclature and guideline to express the amount of a membrane protein synthesized in animal cells in view of bioprocess optimization and production monitoring.
|
670
|
|
|
‡a
Author's Oral and parenteral vaccines against Flavobacterium columnare: evaluation of humoral immune response by ELISA and in vivo efficiency in Nile tilapia
|
670
|
|
|
‡a
Author's Oral and parenteral vaccines against Flavobacterium columnare: evaluation of humoral immune response by ELISA and in vivo efficiency in Nile tilapia (Oreochromis niloticus)
|
670
|
|
|
‡a
Author's Polysaccharide-based membranes loaded with erythromycin for application as wound dressings
|
670
|
|
|
‡a
Author's Polysaccharide-based tissue-engineered vascular patches
|
670
|
|
|
‡a
Author's Preparation and characterization of liposomal systems entrapping the boronated compound o-carboranylpropylamine.
|
670
|
|
|
‡a
Author's Properties of films obtained from biopolymers of different origins for skin lesions therapy
|
670
|
|
|
‡a
Author's Properties of PLA/PCL particles as vehicles for oral delivery of the androgen hormone 17α-methyltestosterone
|
670
|
|
|
‡a
Author's Study of the swelling and stability properties of chitosan-xanthan membranes
|
670
|
|
|
‡a
Author's Supercritical fluid extraction of lycopene from tomato juice and characterization of its antioxidation activity
|
670
|
|
|
‡a
Author's Terapia celular combinada com membranas de biopolímeros melhora a cicatrização de úlceras em paciente com dermatomiosite juvenil
|
670
|
|
|
‡a
Author's The influence of preparation conditions on the characteristics of chitosan-alginate dressings for skin lesions
|
670
|
|
|
‡a
Author's Towards wound dressings with improved properties: Effects of poly
|
670
|
|
|
‡a
Author's Towards wound dressings with improved properties: Effects of poly(dimethylsiloxane) on chitosan-alginate films loaded with thymol and beta-carotene
|
670
|
|
|
‡a
Author's Tuning the properties of alginate-chitosan membranes by varying the viscosity and the proportions of polymers
|
670
|
|
|
‡a
Author's Use of chitosan membrane associated with polypropylene mesh to prevent peritoneal adhesion in rats
|
670
|
|
|
‡a
Author's Waterborne microorganisms and biofilms related to hospital infections: strategies for prevention and control in healthcare facilities
|
909
|
|
|
‡a
(orcid) 000000025813332x
‡9
1
|
909
|
|
|
‡a
(scopus) 7006188042
‡9
1
|
919
|
|
|
‡a
encapsulamentodo5fluorouracilemlipossomasparaadministracaotopica
‡A
Encapsulamento do 5-fluorouracil em lipossomas para administração tópica
‡9
1
|
919
|
|
|
‡a
enhancementofcellularactivityinhyperglycemicmicedermalwoundsdressedwithchitosanalginatemembranes
‡A
Enhancement of cellular activity in hyperglycemic mice dermal wounds dressed with chitosan-alginate membranes
‡9
1
|
919
|
|
|
‡a
enhancementofsf9cellsandbaculovirusproductionemployinggracesmediumsupplementedwithmilkwheyultrafiltrate
‡A
Enhancement of Sf9 Cells and Baculovirus Production Employing Grace's Medium Supplemented with Milk Whey Ultrafiltrate.
‡9
1
|
919
|
|
|
‡a
evaluationofconcentratedmilkwheyasasupplementforsf9spodopterafrugiperdacellsinculture
‡A
Evaluation of concentrated milk whey as a supplement for SF9 Spodoptera frugiperda cells in culture
‡9
1
|
919
|
|
|
‡a
oralandparenteralvaccinesagainstflavobacteriumcolumnareevaluationofhumoralimmuneresponsebyelisaandinvivoefficiencyinniletilapia
‡A
Oral and parenteral vaccines against Flavobacterium columnare: evaluation of humoral immune response by ELISA and in vivo efficiency in Nile tilapia
‡9
1
|
919
|
|
|
‡a
nomenclatureandguidelinetoexpresstheamountofamembraneproteinsynthesizedinanimalcellsinviewofbioprocessoptimizationandproductionmonitoring
‡A
Nomenclature and guideline to express the amount of a membrane protein synthesized in animal cells in view of bioprocess optimization and production monitoring.
‡9
1
|
919
|
|
|
‡a
mechanicallyenhancedpolysaccharidebasedscaffoldsfortissueengineeringofsofttissues
‡A
Mechanically-enhanced polysaccharide-based scaffolds for tissue engineering of soft tissues
‡9
1
|
919
|
|
|
‡a
kineticresponseofadrosophilamelanogastercelllinetodifferentmediumformulationsandcultureconditions
‡A
Kinetic response of a Drosophila melanogaster cell line to different medium formulations and culture conditions.
‡9
1
|
919
|
|
|
‡a
kanamycinincorporationinlipidvesiclespreparedbyethanolinjectiondesignedfortuberculosistreatment
‡A
Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment
‡9
1
|
919
|
|
|
‡a
influenceoftheincorporationoftheantimicrobialagentpolyhexamethylenebiguanideonthepropertiesofdenseandporouschitosanalginatemembranes
‡A
Influence of the incorporation of the antimicrobial agent polyhexamethylene biguanide on the properties of dense and porous chitosan-alginate membranes
‡9
1
|
919
|
|
|
‡a
influenceofcultureconditionsonrecombinantdrosophilamelanogasters2cellsproducingrabiesvirusglycoproteincultivatedinserumfreemedium
‡A
Influence of culture conditions on recombinant Drosophila melanogaster S2 cells producing rabies virus glycoprotein cultivated in serum-free medium
‡9
1
|
919
|
|
|
‡a
evaluationofinvitroantiinflammatoryeffectsofcrudegingerandrosemaryextractsobtainedthroughsupercriticalco2extractiononmacrophageandtumorcelllinetheinfluenceofvehicletype
‡A
Evaluation of in vitro anti-inflammatory effects of crude ginger and rosemary extracts obtained through supercritical CO2 extraction on macrophage and tumor cell line: the influence of vehicle type
‡9
1
|
919
|
|
|
‡a
formationofplaparticlesincorporating17αmethyltestosteronebysupercriticalfluidtechnology
‡A
Formation of PLA particles incorporating 17α-methyltestosterone by supercritical fluid technology
‡9
1
|
919
|
|
|
‡a
formulationofaproteinfreemediumbasedonipl41forthesustainedgrowthofdrosophilamelanogasters2cells
‡A
Formulation of a protein-free medium based on IPL-41 for the sustained growth of Drosophila melanogaster S2 cells.
‡9
1
|
919
|
|
|
‡a
growthofrecombinantdrosophilamelanogasterschneider2cellsproducingrabiesvirusglycoproteininbioreactoremployingserumfreemedium
‡A
Growth of recombinant Drosophila melanogaster Schneider 2 cells producing rabies virus glycoprotein in bioreactor employing serum-free medium
‡9
1
|
919
|
|
|
‡a
hyaluronanchitosannanofilmsassembledlayerbylayerandtheirantibacterialeffectastudyusingstaphylococcusaureusandpseudomonasaeruginosa
‡A
Hyaluronan/chitosan nanofilms assembled layer-by-layer and their antibacterial effect: A study using Staphylococcus aureus and Pseudomonas aeruginosa.
‡9
1
|
919
|
|
|
‡a
improvementofthemechanicalpropertiesofchitosanalginatewounddressingscontainingsilverthroughtheadditionofabiocompatiblesiliconerubber
‡A
Improvement of the mechanical properties of chitosan-alginate wound dressings containing silver through the addition of a biocompatible silicone rubber
‡9
1
|
919
|
|
|
‡a
influenceofatriazinederivativebasedbiocideonmicrobialbiofilmsofcuttingfluidsincontactwithdifferentsubstrates
‡A
Influence of a triazine derivative-based biocide on microbial biofilms of cutting fluids in contact with different substrates
‡9
1
|
919
|
|
|
‡a
incorporationandreleasekineticsof Alpha bisabololfrompclandchitosanguargummembranes
‡A
INCORPORATION AND RELEASE KINETICS OF ALPHA-BISABOLOL FROM PCL AND CHITOSAN/GUAR GUM MEMBRANES
‡9
1
|
919
|
|
|
‡a
advancesintheuseofsupercriticalfluidsfortheproductionofpoly
‡A
Advances in the Use of Supercritical Fluids for the Production of Poly
‡9
1
|
919
|
|
|
‡a
advancesintheuseofsupercriticalfluidsfortheproductionofpolyαhydroxyesterparticlesincorporatingbioactiveagents
‡A
Advances in the Use of Supercritical Fluids for the Production of Poly(α-hydroxyester) Particles Incorporating Bioactive Agents
‡9
1
|
919
|
|
|
‡a
analysisofprocessparametersonthecharacteristicsofliposomespreparedbyethanolinjectionwithaviewtoprocessscaleupeffectoftemperatureandbatchvolume
‡A
Analysis of process parameters on the characteristics of liposomes prepared by ethanol injection with a view to process scale-up: Effect of temperature and batch volume
‡9
1
|
919
|
|
|
‡a
analysisoftheperformanceofpolysaccharidemembranesinaqueousmediaasatooltoassistwounddressingselection
‡A
Analysis of the performance of polysaccharide membranes in aqueous media as a tool to assist wound-dressing selection
‡9
1
|
919
|
|
|
‡a
antibacterialandnoncytotoxicultrathinpolyethyleniminefilm
‡A
Antibacterial and non-cytotoxic ultra-thin polyethylenimine film.
‡9
1
|
919
|
|
|
‡a
avaliacaodopotencialantioxidantedeextratosativosdeplantasobtidosporextracaocomfluidosupercritico
‡A
Avaliação do potencial antioxidante de extratos ativos de plantas obtidos por extração com fluido supercrítico
‡9
1
|
919
|
|
|
‡a
behaviorofwildtypeandtransfecteds2cellsculturedin2differentmedia
‡A
Behavior of wild-type and transfected S2 cells cultured in two different media.
‡9
1
|
919
|
|
|
‡a
biomaterialstypesapplicationsandmarket
‡A
BIOMATERIALS: TYPES, APPLICATIONS, AND MARKET
‡9
1
|
919
|
|
|
‡a
characterizationofchitosanandpolycaprolactonemembranesdesignedforwoundrepairapplication
‡A
Characterization of chitosan and polycaprolactone membranes designed for wound repair application
‡9
1
|
919
|
|
|
‡a
characterizationofcoatingsforopenheartsurgerytubingwithheparinandlipid
‡A
Characterization of coatings for open-heart surgery tubing with heparin and lipid.
‡9
1
|
919
|
|
|
‡a
chitosanalginatemembranesacceleratewoundhealing
‡A
Chitosan-alginate membranes accelerate wound healing.
‡9
1
|
919
|
|
|
‡a
coatedelectrospunbioactivewounddressingsmechanicalpropertiesandabilitytocontrollesionmicroenvironment
‡A
Coated electrospun bioactive wound dressings: Mechanical properties and ability to control lesion microenvironment
‡9
1
|
919
|
|
|
‡a
combiningxanthanandchitosanmembranestomultipotentmesenchymalstromalcellsasbioactivedressingsfordermoepidermalwounds
‡A
Combining xanthan and chitosan membranes to multipotent mesenchymal stromal cells as bioactive dressings for dermo-epidermal wounds.
‡9
1
|
919
|
|
|
‡a
comparativestudyoncomplexesformedbychitosananddifferentpolyanionspotentialofchitosanpectinbiomaterialsasscaffoldsintissueengineering
‡A
Comparative study on complexes formed by chitosan and different polyanions: Potential of chitosan-pectin biomaterials as scaffolds in tissue engineering
‡9
1
|
919
|
|
|
‡a
comparisonofthepropertiesofcompactedandporouslamellarchitosanxanthanmembranesasdressingsandscaffoldsforthetreatmentofskinlesions
‡A
Comparison of the properties of compacted and porous lamellar chitosan-xanthan membranes as dressings and scaffolds for the treatment of skin lesions
‡9
1
|
919
|
|
|
‡a
comparisonofthepropertiesofmembranesproducedwithalginateandchitosanfrommushroomandfromshrimp
‡A
Comparison of the properties of membranes produced with alginate and chitosan from mushroom and from shrimp.
‡9
1
|
919
|
|
|
‡a
compositemembranesofalginateandchitosanreinforcedwithcottonorlinenfibersincorporatingepidermalgrowthfactor
‡A
Composite membranes of alginate and chitosan reinforced with cotton or linen fibers incorporating epidermal growth factor.
‡9
1
|
919
|
|
|
‡a
waterbornemicroorganismsandbiofilmsrelatedtohospitalinfectionsstrategiesforpreventionandcontrolinhealthcarefacilities
‡A
Waterborne microorganisms and biofilms related to hospital infections: strategies for prevention and control in healthcare facilities
‡9
1
|
919
|
|
|
‡a
useofchitosanmembraneassociatedwithpolypropylenemeshtopreventperitonealadhesioninrats
‡A
Use of chitosan membrane associated with polypropylene mesh to prevent peritoneal adhesion in rats
‡9
1
|
919
|
|
|
‡a
tuningthepropertiesofalginatechitosanmembranesbyvaryingtheviscosityandtheproportionsofpolymers
‡A
Tuning the properties of alginate-chitosan membranes by varying the viscosity and the proportions of polymers
‡9
1
|
919
|
|
|
‡a
towardswounddressingswithimprovedpropertieseffectsofpolydimethylsiloxaneonchitosanalginatefilmsloadedwiththymolandbetacarotene
‡A
Towards wound dressings with improved properties: Effects of poly(dimethylsiloxane) on chitosan-alginate films loaded with thymol and beta-carotene
‡9
1
|
919
|
|
|
‡a
towardswounddressingswithimprovedpropertieseffectsofpoly
‡A
Towards wound dressings with improved properties: Effects of poly
‡9
1
|
919
|
|
|
‡a
influenceofpreparationconditionsonthecharacteristicsofchitosanalginatedressingsforskinlesions
‡A
The influence of preparation conditions on the characteristics of chitosan-alginate dressings for skin lesions
‡9
1
|
919
|
|
|
‡a
terapiacelularcombinadacommembranasdebiopolimerosmelhoraacicatrizacaodeulcerasempacientecomdermatomiositejuvenil
‡A
Terapia celular combinada com membranas de biopolímeros melhora a cicatrização de úlceras em paciente com dermatomiosite juvenil
‡9
1
|
919
|
|
|
‡a
supercriticalfluidextractionoflycopenefromtomatojuiceandcharacterizationofitsantioxidationactivity
‡A
Supercritical fluid extraction of lycopene from tomato juice and characterization of its antioxidation activity
‡9
1
|
919
|
|
|
‡a
controlofthepropertiesofporouschitosanalginatemembranesthroughtheadditionofdifferentproportionsofpluronicf68
‡A
Control of the properties of porous chitosan-alginate membranes through the addition of different proportions of Pluronic F68.
‡9
1
|
919
|
|
|
‡a
cultureoftransgenicdrosophilamelanogasterschneider2cellsinserumfreemediabasedontc100basalmedium
‡A
Culture of transgenic Drosophila melanogaster Schneider 2 cells in serum-free media based on TC100 basal medium
‡9
1
|
919
|
|
|
‡a
developmentofpolysaccharidebasedmembranesincorporatingthebioactivecompoundaloin
‡A
Development of polysaccharide-based membranes incorporating the bioactive compound aloin
‡9
1
|
919
|
|
|
‡a
developmentofporouslamellarchitosanalginatemembraneseffectofdifferentsurfactantsonbiomaterialproperties
‡A
Development of porous lamellar chitosan-alginate membranes: Effect of different surfactants on biomaterial properties
‡9
1
|
919
|
|
|
‡a
differentiationofdentalpulpstemcellsintochondrocytesuponcultureonporouschitosanxanthanscaffoldsinthepresenceofkartogenin
‡A
Differentiation of dental pulp stem cells into chondrocytes upon culture on porous chitosan-xanthan scaffolds in the presence of kartogenin
‡9
1
|
919
|
|
|
‡a
dispersionandreleaseofembelinfromelectrospunbiodegradablepolymericmembranes
‡A
Dispersion and release of embelin from electrospun, biodegradable, polymeric membranes
‡9
1
|
919
|
|
|
‡a
drosophilamelanogasters2cellsforexpressionofheterologousgenesfromgenecloningtobioprocessdevelopment
‡A
Drosophila melanogaster S2 cells for expression of heterologous genes: From gene cloning to bioprocess development
‡9
1
|
919
|
|
|
‡a
effectsofchitosansolutionconcentrationandincorporationofchitinandglycerolondensechitosanmembraneproperties
‡A
Effects of chitosan solution concentration and incorporation of chitin and glycerol on dense chitosan membrane properties
‡9
1
|
919
|
|
|
‡a
effectsofdifferentsterilizationmethodsonthemorphologymechanicalpropertiesandcytotoxicityofchitosanmembranesusedaswounddressings
‡A
Effects of different sterilization methods on the morphology, mechanical properties, and cytotoxicity of chitosan membranes used as wound dressings
‡9
1
|
919
|
|
|
‡a
effectsofelectrospunfibrousmembranesofpolycaprolactoneandchitosanpolyethyleneoxideonmouseacuteskinlesions
‡A
Effects of Electrospun Fibrous Membranes of PolyCaprolactone and Chitosan/Poly(Ethylene Oxide) on Mouse Acute Skin Lesions
‡9
1
|
919
|
|
|
‡a
studyoftheswellingandstabilitypropertiesofchitosanxanthanmembranes
‡A
Study of the swelling and stability properties of chitosan-xanthan membranes
‡9
1
|
919
|
|
|
‡a
propertiesofplapclparticlesasvehiclesfororaldeliveryoftheandrogenhormone17αmethyltestosterone
‡A
Properties of PLA/PCL particles as vehicles for oral delivery of the androgen hormone 17α-methyltestosterone
‡9
1
|
919
|
|
|
‡a
propertiesoffilmsobtainedfrombiopolymersofdifferentoriginsforskinlesionstherapy
‡A
Properties of films obtained from biopolymers of different origins for skin lesions therapy
‡9
1
|
919
|
|
|
‡a
preparationandcharacterizationofliposomalsystemsentrappingtheboronatedcompoundocarboranylpropylamine
‡A
Preparation and characterization of liposomal systems entrapping the boronated compound o-carboranylpropylamine.
‡9
1
|
919
|
|
|
‡a
polysaccharidebasedtissueengineeredvascularpatches
‡A
Polysaccharide-based tissue-engineered vascular patches
‡9
1
|
919
|
|
|
‡a
polysaccharidebasedmembranesloadedwitherythromycinforapplicationaswounddressings
‡A
Polysaccharide-based membranes loaded with erythromycin for application as wound dressings
‡9
1
|
919
|
|
|
‡a
oralandparenteralvaccinesagainstflavobacteriumcolumnareevaluationofhumoralimmuneresponsebyelisaandinvivoefficiencyinniletilapiaoreochromisniloticus
‡A
Oral and parenteral vaccines against Flavobacterium columnare: evaluation of humoral immune response by ELISA and in vivo efficiency in Nile tilapia (Oreochromis niloticus)
‡9
1
|
919
|
|
|
‡a
effectsofsupercriticalcarbondioxideprocessingonthepropertiesofchitosanalginatemembranes
‡A
Effects of supercritical carbon dioxide processing on the properties of chitosan–alginate membranes
‡9
1
|
919
|
|
|
‡a
electrospunmultilayerchitosanscaffoldsaspotentialwounddressingsforskinlesions
‡A
Electrospun multilayer chitosan scaffolds as potential wound dressings for skin lesions
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
LC|no2008017879
|
996
|
|
|
‡2
LIH|LNB:C_v_X_z_;=C_b_
|
996
|
|
|
‡2
PTBNP|1626465
|
996
|
|
|
‡2
CAOONL|ncf10897986
|
996
|
|
|
‡2
ISNI|0000000083897976
|
996
|
|
|
‡2
BLBNB|000300256
|
996
|
|
|
‡2
BNF|14208436
|
996
|
|
|
‡2
ISNI|000000050047457X
|
996
|
|
|
‡2
ISNI|0000000451775228
|
996
|
|
|
‡2
B2Q|0000910313
|
996
|
|
|
‡2
BNE|XX994048
|
996
|
|
|
‡2
DNB|135321433
|
996
|
|
|
‡2
ISNI|0000000067459458
|
996
|
|
|
‡2
BLBNB|001413179
|
996
|
|
|
‡2
ISNI|0000000081184358
|
996
|
|
|
‡2
SUDOC|149190409
|
996
|
|
|
‡2
PTBNP|1153299
|
996
|
|
|
‡2
ARBABN|000054756
|
996
|
|
|
‡2
LC|n 2021250260
|
996
|
|
|
‡2
LC|no2019082329
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|